Advertisement
Advertisement

ENVB

ENVB logo

Enveric Biosciences, Inc. Common Stock

4.15
USD
Sponsored
+0.12
+3.07%
Jan 07, 16:00 UTC -5
Closed
exchange

Pre-Market

4.14

-0.01
-0.12%

ENVB Earnings Reports

Positive Surprise Ratio

ENVB beat 11 of 16 last estimates.

69%

Next Report

Date of Next Report
Mar 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.31
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
-99.46%

Enveric Biosciences, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, ENVB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.35 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.30% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.31 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Enveric Biosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -3.3%, changed from $5.46 before the earnings release to $5.28 the day after.
The next earning report is scheduled for Mar 26, 2026.
Based on 3 analysts, Enveric Biosciences, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement